Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Eli Lilly (LLY.US): Retatrutide achieved significant weight loss effects and met all primary endpoints in Phase III trials.

Eli Lilly (LLY.US): Retatrutide achieved significant weight loss effects and met all primary endpoints in Phase III trials.

智通财经智通财经2026/07/23 11:41
Show original
Eli Lilly (LLY.US): Retatrutide achieved significant weight loss effects and met the primary endpoints in phase III trials.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!